| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,857 | 12,415 | 12,561 | 13,804 | | Cost of Revenue | 7,607 | 8,233 | 8,685 | 8,875 | | | Gross Profit |
-
| 4,181 | 3,877 | 4,929 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,975 | 6,886 | 6,139 | 12,833 | | Non Recurring | 2,113 |
-
|
-
|
-
| | Others | 7,590 | 5,621 | 3,110 | 12,887 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (8,326) | (5,372) | (20,791) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (8,428) | (8,326) | (5,372) | (20,791) | | Interest Expense | 560 | 579 | 589 | 685 | | Income Before Tax | (8,988) | (8,905) | (5,961) | (21,476) | | Income Tax Expense |
-
| 822 | (822) | 2,196 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,988) | (9,727) | (5,139) | (23,672) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (658) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,988) | (9,727) | (5,139) | (24,331) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,988) | ($9,727) | ($5,139) | ($24,331) |
|
0.03% Nasdaq 
0.12 (23.22%) 
Income Statement
